TruthArchive.ai - Related Video Feed

The speaker discusses the spread of bird flu and the potential for mass culling of poultry. They mention the development of bird flu vaccines and the possibility of human-to-human transmission. The conversation also touches on the lack of human trials for vaccines and the FDA's approval process based on preclinical data. The focus is on the need for vaccination, particularly for farm workers.

In 2024, the H5N1 bird flu virus jumped from wild birds to cows, shocking virus experts. The virus has since spread rapidly through US dairy herds and poultry flocks, infecting other mammals, including 70 Americans, one of whom died. Some experts claim the Biden administration was slow to respond, while the Trump administration laid off over 100 scientists. The virus spreads easily via milking equipment, and workers have also become infected. Experts fear the virus's pandemic potential, especially given its high mortality rate in past outbreaks. Testing was slow to start, and some states still test infrequently. A new strain in cattle has led to more severe disease in some people. The virus has spread to foxes, goats, pigs, rats, cats, and raccoons. Antibody tests on dairy workers revealed a 7% infection rate, suggesting many cases go undetected. Experts are concerned that the virus could evolve into a pandemic strain. A bird flu vaccine exists but isn't FDA-licensed, and the Trump administration paused funding for Moderna's vaccine. The USDA's milk testing program has helped slow the spread, but distrust of science and vaccines hinders prevention efforts. Some scientists claim the CDC influenza division has been decimated and that a communications ban has been put on federal workers.

The call aims to unite four public health agencies to discuss the current situation regarding HPAI, particularly H5N1, and to share lessons learned about surveillance and epidemiology. CFIA presented their enhanced poultry surveillance plans, including efforts related to cattle and milk. The UK Health Security Agency shared insights from their asymptomatic human surveillance pilot. Don Sheppard emphasized the need for developing an assay for H5N1 to prepare for potential positive test results. He highlighted the challenges in determining the appropriate populations and techniques for serosurveillance, including the lack of serum samples from humans or cattle with H5N1. Ongoing discussions and work are focused on protocol development to ensure readiness for any developments in the situation.

Bird flu may be a scam to push gain of function research in US labs. CDC confirmed it. The timing seems suspicious before the WHO meeting and elections. Michigan declared a bird flu emergency, leading to mass testing and culling of poultry. This could cause food shortages. However, bird flu can be treated in humans. The Global Vaccine Alliance calls it "disease x," which could create food insecurity and fear before the elections.

The speaker discusses the global wildlife trade and its connection to the emergence of new diseases. They focus on SARS and how it originated from a wildlife market. Through surveillance of bats in Southern China, they have discovered over 100 new SARS-related coronaviruses that pose a threat to humans. Some of these coronaviruses can infect human cells and cause SARS-like disease. The speaker emphasizes the need for continued surveillance and understanding of these spillover events, as any one of them could potentially lead to a pandemic. They also mention the challenges in developing vaccines and antivirals for these diverse coronaviruses.

The Biden administration should prioritize two key actions regarding bird flu. First, they need to increase testing availability, especially rapid home tests for farm workers and their families, to ensure we are aware of the virus's presence. Second, there is an existing vaccine for H5N1 that has not yet been authorized by the FDA. The administration should expedite this process to distribute the vaccine to farm workers and vulnerable populations. The urgency is heightened by uncertainty about future actions from the Trump administration, which could affect testing and vaccine authorization. Bird flu has a high mortality rate, particularly in vulnerable groups, making it crucial to prevent its spread and mutations.

We need to pay attention to several emerging health threats. Starting January 21st, H5N1 is spreading among wild birds and poultry in the western U.S., with sporadic human cases reported. There's a risk of human-to-human transmission. Additionally, a new coronavirus may be developing in Asia, and mosquito-borne viruses like dengue and Zika could return along the Gulf Coast. Vaccine-preventable diseases are also on the rise due to anti-vaccine sentiments, with a fivefold increase in whooping cough cases and multiple measles outbreaks this year. Polio has been detected in New York's wastewater. A strong response team is essential to address these challenges effectively.

The transmission of avian bird flu from animals to humans is rare. We should allow farms with chickens and cows to develop natural immunity, as they are constantly being reinfected by migratory mallard ducks and waterfowl. The practice of culling is not effective.

In 2024, the H5N1 bird flu virus jumped from wild birds to cows, shocking virus experts. The virus has since spread rapidly through US dairy herds and poultry, infecting other mammals, including 70 Americans, one of whom died. Some experts claim the Biden administration was slow to respond, while the Trump administration laid off scientists. The virus spreads easily and lingers on milking equipment, infecting workers. Experts fear the virus's pandemic potential, citing its high mortality rate in past outbreaks. Testing was slow to start, and some states still test infrequently. A new strain in cattle has led to more severe disease in some people. The virus has spread to foxes, goats, pigs, rats, cats, and raccoons. Some studies suggest many human cases go undetected. Experts worry that the virus could evolve into a pandemic strain. A bird flu vaccine exists but is not FDA-licensed, and the Trump administration paused funding for Moderna's vaccine. The USDA's milk testing program has helped slow the spread, but distrust of science and vaccines hinders prevention efforts.

It seems that bird flu, a gain-of-function strain, is causing concern. The strain possibly originated from the USDA Poultry Research Lab in Georgia. Former CDC director Redfield mentioned that manipulating the virus could make it transmissible to humans. Interestingly, the director of the lab has ties to the Gates Foundation. This raises questions about the origins and implications of the outbreak.

All countries experiencing H5 outbreaks in animals are urged to share viral samples and sequences with the WHO Global Influenza Surveillance and Response System (GISRIS).

The call brought together public health agencies to discuss HPAI H5N1 surveillance and research. CFIA presented enhanced poultry surveillance plans, while the UK Health Security Agency shared their asymptomatic human surveillance pilot. Don Sheppard from PHAC emphasized the need for developing an assay for H5N1 testing. Discussions revolved around the extent of surveillance, target populations, and assay validation challenges due to limited serum samples. Protocol development is underway to prepare for potential positive test results.

Bird flu could potentially lead to a pandemic that is much more severe than COVID-19. It's not a matter of if, but when this will happen. When bird flu infects humans, it has a high mortality rate, estimated between 25% and 50%. The situation becomes critical once the virus can attach to human receptors and spread from person to person. Given these factors, it is likely that we will face a bird flu pandemic in the future.

The concerning issue is that the virus can infect multiple species, including pigs, which are often in close proximity to chickens and cows. This interaction raises the risk of a reassortment of viruses, potentially creating a new strain that combines the dangerous traits of H5N1 with the ability to spread between humans. Public health officials are particularly worried about this possibility due to the mixing of viruses in pigs. Although the current risk is considered low, the CDC emphasizes the need for vigilance as the situation could change.

The transcript discusses self-amplifying replicon mRNA injections and asserts that they are being deployed for both humans and animals globally. It states that the UK approved Arcturus Therapeutics’ self-amplifying COVID-19 vaccine for adults over 18, and that the European Union previously approved the same inoculation for adults, placing it in both the EU and the UK. It also claims that Japan approved it in 2023, and that India has approved these replicon injections as well, indicating a global rollout. It highlights that in the United States, the USDA approved the self-amplifying mRNA particle injections for pets, specifically mentioning Merck’s Novavax NXT for dogs and cats, and asserts that this is being injected into pets and that shedding onto human owners across the US is possible. It notes that the FDA has fast-tracked an H5N1 bird flu replicon injection trial, emphasizing concern about these developments. The speaker outlines purported dangers of these replicating genetic materials, including the possibility of shedding from humans to humans or from pets to humans, and the potential for recombination with wild viruses to create chimeric mutants. It emphasizes the claimed approval of Arcturus Therapeutics’ injection “everywhere in the clinical trials” and then provides adverse event statistics: eighty-five percent suffered systemic adverse events, and fifteen percent required medical attention. A Uganda study is cited, claiming that the replicon injections induced severe blood abnormalities in ninety-three percent of recipients, with thrombocytopenia, lymphopenia, and neutropenia reported, implying degraded immune systems and increased risks of internal bleeding in a majority of participants. The Uganda study is also described as showing eighty-five percent experiencing vomiting, high fevers, and feeling absolutely terrible. The speaker concludes with a strong stance against these injections, calling them a “self amplifying assault on humanity” and arguing that they should be pulled off the market and banned for human use. The overall message is a warning about global deployment, potential shedding and recombination risks, significant adverse event rates, and a call to ban self-amplifying mRNA injections for humans. The named entities include Arcturus Therapeutics, Merck, Novavax NXT, and references to regulatory actions in the UK, EU, Japan, India, and the US.

In 2015, the National Library of Medicine published a study by 15 virologists and medical experts warning that SARS-like bat coronaviruses pose a potential threat to humans. The scientists, with decades of experience in studying coronaviruses, examined how SARS and MERS transmitted among humans. They modified a strain of coronavirus from Chinese horseshoe bats using gain of function technology and injected it into mice spinal cords. This study not only highlights the dangers of coronaviruses in bats but also demonstrates efforts to amplify the virus's contagion ability to better understand and prepare for future outbreaks.

We need to be concerned about several emerging health threats starting January 21st. H5N1 is spreading among wild birds and poultry in the western U.S., with sporadic human cases reported. There's potential for human-to-human transmission. Additionally, a new coronavirus may be developing in Asia, following the patterns of SARS and COVID-19. Mosquito-borne viruses like dengue, Zika, and possibly yellow fever are expected to resurge along the Gulf Coast. Vaccine-preventable diseases are also on the rise, with a fivefold increase in whooping cough cases and multiple measles outbreaks this year. Polio has been detected in New York's wastewater. A strong response team will be crucial to manage these challenges effectively.

Speaker 0: Extremely dangerous self amplifying replicon mRNA injections are currently being deployed for humans and animals across the globe. A few days ago, The UK approved Arcturus Therapeutics self amplifying COVID nineteen injection for adults over 18. Previously, the European Union approved the same Arcturus Therapeutics replicon injection for adults. So it's in The EU. It's in The UK. Japan approved it in 2023. So it's being injected into Japanese citizens as well as India. India has approved these replicon injections as well. And so it is being rolled out across the globe and here in The US is very worrisome. The USDA approved the self amplifying mRNA particle injections for our dogs and cats. This is Novavac NXT by Merck. And so that's actively being injected into our, our pets and probably shedding onto human owners across The United States as well in The US. Our FDA fast tracked an h five n one bird flu replicon injection trial, and we have to remember just how dangerous these are. So not only can they likely shed this replicating genetic material can shed onto other humans or from our pets to humans to the human owners, but they can also recombine with wild viruses and and create these chimeric mutants. But what's most important is this Arcturus Therapeutics injection being approved everywhere in the in the clinical trials for them. Eighty five percent suffered systemic adverse events, fifteen percent required medical attention. And then a recent study in Uganda, it induced severe blood abnormalities in ninety three percent of the recipients. They suffered from thrombocytopenia, lymphopenia, neutropenia. So their immune systems were being degraded, and they were suffering inter increased risks of internal bleeding in a majority of participants. And eighty five percent of them were vomiting, had high fevers, and felt absolutely terrible. So this self amplifying assault on humanity needs to come to an end. We have to pull these off of the market and ban them for human use.

Vet was not allowed to take blood, and let's go into the reason why. So the vet said that they said it doesn't matter if all of these animals remember this. If every one of these animals test negative, they're still to die. And the reason being is because of that international trade policy between the World Animal Health Organization and the World Health Organization, which takes the directives of the United Nations. Good morning, Tina. And then the the minute anybody that any animal has a positive test on a property for HPAI, avian influenza, all animals are to be destroyed to protect our

The call brought together public health agencies to discuss the HPAI H5N1 trajectory, focusing on enhanced surveillance and scientific efforts. CFIA presented enhanced poultry surveillance plans, while the UK Health Security Agency discussed their asymptomatic human surveillance pilot. PHAC emphasized the need to develop an assay for H5N1 testing. Technical questions remain about assay validation and population testing techniques. Work is ongoing to address these challenges and ensure preparedness for potential positive cases.

We need to be concerned about several emerging health threats starting January 21st. H5N1 is spreading among wild birds and poultry in the western U.S., with sporadic human cases reported. There's potential for human transmission. Additionally, a new coronavirus may be developing in Asia, following previous outbreaks like SARS and COVID-19. Mosquito-borne viruses, such as dengue and possibly Zika, are also expected to resurface along the Gulf Coast. Vaccine-preventable diseases are on the rise due to anti-vaccine movements, with a fivefold increase in whooping cough cases and multiple measles outbreaks. Polio has been detected in New York's wastewater. These challenges will require a strong response team to manage effectively.

We need to pay attention to several emerging health threats starting January 21st. H5N1 is spreading among wild birds and poultry, with sporadic human cases reported, though no human-to-human transmission has occurred yet. Additionally, a new coronavirus may be developing in Asia, following previous outbreaks like SARS and COVID-19. Mosquito-borne viruses, such as dengue and potentially Zika, are expected to resurface along the Gulf Coast. Vaccine-preventable diseases are also on the rise, with a fivefold increase in whooping cough cases and multiple measles outbreaks this year, alongside polio detected in New York's wastewater. These challenges will require a strong response team to manage effectively.

In Quebec, the concern about H5N1 avian influenza is not high among the general population, but authorities are vigilant. There is a call for coordination between agricultural and health agencies at the national level in Canada. Funding is being allocated to address knowledge gaps, and there is a focus on pandemic preparedness. It is suggested to expand surveillance efforts to include goat and sheep milk testing. Communication strategies and preparedness for potential positive cases in Canada are emphasized. In British Columbia, there is interest due to past avian influenza outbreaks in poultry. Vigilance is urged, especially regarding raw milk products and potential risks to pets.

Researchers have been working on making bird flu more contagious for humans through gain of function research. The virus mainly infects chickens and sometimes cattle. Chinese vaccination efforts in the 90s may have worsened the situation. The current strain, H5N1 avian influenza, has caused around 800-900 human cases with a high mortality rate in Southeast Asia. Recent US cases were easily treated. The virus is not a significant threat unless it starts spreading human to human. The recent strain may have originated from experiments on mallard ducks in Georgia, leading to its spread across states. The media has not questioned this spread caused by migratory waterfowl.

We need to be concerned about several emerging health threats. Starting January 21st, H5N1 is spreading among wild birds in the western U.S. and has reached poultry, with sporadic human cases reported. There's potential for human-to-human transmission. Additionally, a new coronavirus may be developing in Asia, following previous outbreaks like SARS and COVID-19. Mosquito-borne viruses, such as dengue and possibly Zika, are expected to return along the Gulf Coast. Vaccine-preventable diseases are rising due to anti-vaccine sentiments, with a fivefold increase in whooping cough cases and multiple measles outbreaks. Polio has also been detected in New York's wastewater. A strong response team will be essential to manage these challenges effectively.